105 studies found for:    interstitial lung disease AND children
Show Display Options
Rank Status Study
21 Completed Panitumumab for Intravenous Infusion 100 mg and 400 mg Special Drug Use Surveillance "Survey on Unresectable, Advanced or Recurrent Colorectal Cancer With Wild-type KRAS Gene" (All-patient Surveillance)
Condition: Advanced or Recurrent Colorectal Cancer
Intervention: Drug: Panitumumab
22 Completed Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Biological DMARDs;   Drug: Non-Biologic DMARDs
23 Recruiting Tagrisso Tablets Clinical Experience Investigation (All Case Investigation)
Condition: All Patients Treated With the Product
Intervention:
24 Terminated Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
Conditions: Bronchopulmonary Dysplasia;   Respiratory Distress Syndrome;   Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature
Interventions: Procedure: Minimal mechanical ventilation management;   Procedure: Routine mechanical ventilation management;   Drug: Dexamethasone;   Drug: Placebo
25 Completed Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
Conditions: Lung Diseases;   Pulmonary Fibrosis;   Lung Diseases, Interstitial;   Scleroderma, Systemic
Intervention:
26 Completed Idiopathic Pulmonary Fibrosis: a Case-control Study
Conditions: Lung Diseases;   Pulmonary Fibrosis;   Lung Diseases, Interstitial
Intervention:
27 Completed Drug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor Antagonists
Conditions: Hospitalized Cases of Angioneurotic Oedema;   Pneumonia;   Gastroenteritis;   Failure to Thrive;   Seizures;   Acute Interstitial Nephritis and Thrombocytopenia
Intervention:
28 Unknown  Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications
Conditions: Lung Neoplasm;   Lung Diseases, Interstitial;   Respiratory Tract Infections;   Pleural Effusions
Intervention: Procedure: Respiratory endoscopy
29 Completed The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
Condition: HIV Infections
Intervention: Drug: Zidovudine
30 Completed Lung Diffusing Capacity for Nitric Oxide as a Marker of Fibrotic Changes in Idiopathic Interstitial Pneumonias
Conditions: Usual Interstitial Pneumonia;   Nonspecific Interstitial Pneumonia
Intervention:
31 Terminated DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)
Conditions: Pneumonia, Interstitial Plasma Cell;   Pneumocystis Carinii Pneumonia;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Pafuramidine maleate (DB289);   Drug: Trimethoprim-Sulfamethoxazole (TMP-SMX)
32 Completed Herpesvirus in Idiopathic Pulmonary Fibrosis
Conditions: Lung Diseases;   Herpesvirus Infections
Intervention:
33 Recruiting A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Condition: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
Intervention: Drug: Prograf
34 Recruiting Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
35 Unknown  Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
Conditions: Interstitial Pneumonitis;   Polymyositis;   Dermatomyositis
Intervention: Drug: Tacrolimus
36 Terminated An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Lung Disease
Intervention: Drug: Interferon gamma-1b
37 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
38 Completed Specialized Center of Research in Occupational and Immunologic Lung Disease
Conditions: Lung Diseases, Obstructive;   Asbestosis;   Silicosis;   Pneumoconiosis;   Chronic Obstructive Pulmonary Disease
Intervention:
39 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate
40 Recruiting Pediatric Vasculitis Initiative
Conditions: Wegeners Granulomatosis (Granulomatosis With Polyangiitis);   Microscopic Polyangiitis;   Churg Strauss Syndrome (Eosinophilic Granulomatosis With Polyangiitis);   Polyarteritis Nodosa;   Takayasu Arteritis;   Primary CNS Vasculitis;   Unclassified Vasculitis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years